A possible role for genetic factors in the aetiology of Parkinson's disease, thought for several years to be negligible on the basis of similar concordance rates for monozygotic and dizygotic twin pairs,' has recently attracted substantial interest. This has been fuelled by reports of two large pedigrees seemingly exhibiting autosomal dominant inheritance,3 and studies of unaffected cotwins of patients with Parkinson's disease with PET which suggested a high incidence of subclinical Parkinson's disease in these subjects. 4 Given the existence of parkinsonism induced by 1- methyl-4-phenyl-1 ,2,3,6-tetrahydropyridine (MPTP),' an attractive hypothesis for the aetiology of Parkinson's disease is one of genetic susceptibility to an environmental toxin. This has been explored by investigating metabolism of debrisoquine, a drug which is hydroxylated by an enzyme in the hepatic microsomal oxidative cytochrome P-450 system, specifically debrisoquine 4-hydroxylase (CYP2D6).
Impaired debrisoquine metabolism is found in 5% to 10% of caucasian populations; it is an autosomal recessive trait caused by muta (table 3) . Table 4 shows the results of two point linkage analysis. 
